A new research paper summarises recent advances in health span biotechnology discussed at the 2023 Aging Research and Drug Discovery Meeting (ARDD), where leading experts reviewed breakthroughs in artificial intelligence (AI), biomarkers, aging clocks, geroscience, and clinical trials that support healthier, longer lives.
The authors have presented a comprehensive view, published as the cover of Aging, of how these technologies are shaping research and industry approaches to ageing, focusing on targeting ageing itself to reduce multiple age-related diseases and extend the healthy years of life.
With people living longer, addressing age-related health issues is more critical than ever. Traditional healthcare often treats age-related diseases individually, overlooking ageing as a core issue.
Longevity biotechnology seeks to change this by combining AI with biomarker analysis to detect early signs of ageing, enabling targeted interventions that not only delay disease but also promote longer, healthier lives.
The research synthesises the potential of AI to identify precise biomarkers of ageing, supporting the development of “ageing clocks”—tools that use biological data to estimate a person’s biological age and health risks.
These tools help clinicians tailor prevention and treatment to individual needs. Additionally, AI speeds up the discovery of drugs that target primary ageing drivers, such as cellular damage and decreased cellular energy, offering the potential to slow, prevent, or even reverse certain effects of ageing and enhance quality of life.
The authors write: “The fusion of AI with biomarker research has markedly revolutionised the way biomarkers are identified and validated in the field of ageing.”
This approach not only promises to slow, prevent, or even reverse certain effects of ageing but also emphasises the potential for AI-driven methods to extend health spans.
In conclusion, the authors emphasises the need for continued investment in AI-driven therapies and biomarker research, which hold the potential to redefine ageing care and improve health outcomes as people grow older.
